The paradox of clozapine in Black people with treatment-resistant schizophrenia

被引：0
作者：
Whiskey, Eromona [1 ,2 ]
Bachmann, Christian [3 ]
Dzahini, Olubanke [1 ,2 ]
Taylor, David [1 ,2 ]
Oloyede, Ebenezer [1 ,4 ]
机构：
[1] Maudsley Hosp & Inst Psychiat, Pharm Dept, London, England
[2] Kings Coll London, Inst Pharmaceut Sci, London, England
[3] Univ Hosp Ulm, Dept Child & Adolescent Psychiat, Ulm, Germany
[4] Univ Oxford, Dept Psychiat, Oxford, England
来源：
NATURE MENTAL HEALTH | 2025年 / 3卷 / 04期
关键词：
BENIGN ETHNIC NEUTROPENIA; UNTREATED PSYCHOSIS; MENTAL-HEALTH; RACIAL DISPARITIES; PRESCRIPTION PATTERNS; DURATION; PATHWAYS; DISCONTINUATION; CARE; SERVICES;
D O I：
10.1038/s44220-025-00411-9
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
Clozapine is currently the only licensed medication for treatment-resistant schizophrenia (TRS). Ethnic inequalities in treatment with clozapine have been described extensively, particularly regarding the effect on Black ethnic groups. Here we explore the reasons for clozapine underuse in this population, identifying potential misconceptions and providing suggestions to address these barriers.
引用
收藏
页码：402 / 407
页数：6
相关论文
共 85 条
  • [1] CLOZAPINE-INDUCED AGRANULOCYTOSIS - SITUATION REPORT UP TO AUGUST 1976
    ANDERMAN, B
    GRIFFITH, RW
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 11 (03) : 199 - 201
  • [2] The pathways to mental health care of first-episode psychosis patients: a systematic review
    Anderson, K. K.
    Fuhrer, R.
    Malla, A. K.
    [J]. PSYCHOLOGICAL MEDICINE, 2010, 40 (10) : 1585 - 1597
  • [3] Determinants of negative pathways to care and their impact on service disengagement in first-episode psychosis
    Anderson, Kelly K.
    Fuhrer, Rebecca
    Schmitz, Norbert
    Malla, Ashok K.
    [J]. SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2013, 48 (01) : 125 - 136
  • [4] Re-examining the utility and validity of benign ethnic neutropenia: A narrative literature review
    Andreou, Ashley
    Jayaram, Jyotsna
    Walker, Ashley
    Tek, Cenk
    Williams, J. Corey
    [J]. SCHIZOPHRENIA RESEARCH, 2023, 253 : 48 - 53
  • [5] Genetic identification of undiagnosed benign ethnic neutropenia in patients receiving clozapine treatment
    Aziri, Helena
    Vallianatou, Kalliopi
    Balgobin, Bhirundra
    Taylor, David
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2024,
  • [6] Understanding ethnic inequalities in mental healthcare in the UK: A meta-ethnography
    Bansal, Narinder
    Karlsen, Saffron
    Sashidharan, Sashi P.
    Cohen, Rachel
    Chew-Graham, Carolyn A.
    Malpass, Alice
    [J]. PLOS MEDICINE, 2022, 19 (12)
  • [7] Variation in Psychotropic Medication Prescription for Adults With Schizophrenia in the United States
    Bareis, Natalie
    Olfson, Mark
    Wall, Melanie
    Stroup, T. Scott
    [J]. PSYCHIATRIC SERVICES, 2022, 73 (05) : 492 - 500
  • [8] Community treatment orders and associations with readmission rates and duration of psychiatric hospital admission: a controlled electronic case register study
    Barkhuizen, Wikus
    Cullen, Alexis E.
    Shetty, Hitesh
    Pritchard, Megan
    Stewart, Robert
    McGuire, Philip
    Patel, Rashmi
    [J]. BMJ OPEN, 2020, 10 (03):
  • [9] Ethnic variations in compulsory detention under the Mental Health Act: a systematic review and meta-analysis of international data
    Barnett, Phoebe
    Mackay, Euan
    Matthews, Hannah
    Gate, Rebecca
    Greenwood, Helen
    Ariyo, Kevin
    Bhui, Kamaldeep
    Halvorsrud, Kristoffer
    Pilling, Stephen
    Smith, Shubulade
    [J]. LANCET PSYCHIATRY, 2019, 6 (04): : 305 - 317
  • [10] Racial Disparities in Clozapine Prescription Patterns Among Patients With Schizophrenia
    Barry, Spenser
    Jarskog, L. Fredrik
    Xia, Kai
    Torpunuri, Rohit Simha
    Wu, Xiaoyu
    Zeng, Xiaoming
    [J]. PSYCHIATRIC SERVICES, 2024, 75 (08) : 733 - 739
123456789